39
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Clinical and radiographic results from a 2-year comparison of once-weekly versus twice-weekly administration of etanercept in biologics-naive patients with rheumatoid arthritis

, , , &
Pages 824-830 | Received 14 Sep 2011, Accepted 22 Dec 2011, Published online: 02 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Giuseppe Murdaca, Francesca Spanò, Miriam Contatore, Andrea Guastalla, Ottavia Magnani & Francesco Puppo. (2014) Efficacy and safety of etanercept in chronic immune-mediated disease. Expert Opinion on Drug Safety 13:5, pages 649-661.
Read now
Xi Xie, David Zhang, Jin-wei Chen, Jing Tian, Guang-hui Ling & Fen Li. (2014) Pharmacogenomics of biological treatment in rheumatoid arthritis. Expert Opinion on Biological Therapy 14:2, pages 157-164.
Read now

Articles from other publishers (3)

Niels Graudal, Benjamin Skov Kaas-Hansen, Louise Guski, Thorbjørn Hubeck-Graudal, Nicky J. Welton & Gesche Jürgens. (2019) Different Original and Biosimilar TNF Inhibitors Similarly Reduce Joint Destruction in Rheumatoid Arthritis—A Network Meta-Analysis of 36 Randomized Controlled Trials. International Journal of Molecular Sciences 20:18, pages 4350.
Crossref
Yasuyuki Tomita. (2018) Long-Term Clinical Efficacy, Retention Rate, and Safety of 25 mg/week Etanercept in Patients with Rheumatoid Arthritis関節リウマチにおけるエタネルセプト 25 mg/週の長期臨床効果,治療継続率,安全性の検討. Journal of Nihon University Medical Association 77:4, pages 229-235.
Crossref
Mariagrazia Lorenzin, Augusta Ortolan, Manouk de Hooge, Paola Frallonardo, Antonio Piccoli, Franco Cozzi, Francesca Oliviero, Leonardo Punzi & Roberta Ramonda. (2015) Lengthening the time intervals between doses of biological agents in psoriatic arthritis patients: A single-center retrospective study. International Journal of Immunopathology and Pharmacology 28:4, pages 479-487.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.